Trial intelligence / Profile preview

Effects of Dronabinol on Phenotypes in Schizophrenia with Cannabis Use

NCT01832766Phase 2Terminated

Sponsor
University of Colorado Denver
Start
Jun 2005
Primary completion
May 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in schizophrenia comparing Dronabinol First with Placebo First (2 arms). Primary endpoint: P50 Auditory Evoked Potential. Started Jun 2005; status: terminated.

02

Drugs

dronabinol
03

Conditions

schizophrenia

Beyond the preview

Go deeper on NCT01832766.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01832766.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call